Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
Authors:
- R. BurkesRBR. Burkes
- Y. CormierYCY. Cormier
- M. CrumpMCM. Crump
- R. FeldRFR. Feld
- T. StrackTST. Strack
- 1 February 1996
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 14 (1) , 135-144
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Gemcitabine: current status of phase I and II trials.Journal of Clinical Oncology, 1994
- Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literatureLung Cancer, 1991
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in CancerBiometrics, 1990
- Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the futureCancer Treatment Reviews, 1983
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage SchedulesAnnals of Internal Medicine, 1981